| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Adam Z. Blatt | |
| Viviana P. Ferreira | |||
| Sabina Pathan | |||
| P2860 | cites work | Cathepsin G activates protease-activated receptor-4 in human platelets | Q22253276 |
| Bivalent and co-operative binding of complement factor H to heparan sulfate and heparin | Q24311571 | ||
| Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement | Q24529520 | ||
| Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome | Q24543850 | ||
| Control of the amplification convertase of complement by the plasma protein beta1H | Q24561671 | ||
| Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases | Q24632001 | ||
| The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1 | Q24673214 | ||
| Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution | Q24684822 | ||
| Structural and functional characterization of the product of disease-related factor H gene conversion | Q27677168 | ||
| Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome | Q28168804 | ||
| The role of selectins in inflammation and disease | Q28182332 | ||
| The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena | Q28210676 | ||
| A new map of glycosaminoglycan and C3b binding sites on factor H | Q28289935 | ||
| Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure | Q28301693 | ||
| Polyanion-induced self-association of complement factor H. | Q37181643 | ||
| Interleukin 18 in the heart | Q37194396 | ||
| Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O). | Q37200463 | ||
| The C-terminus of complement factor H is essential for host cell protection | Q37238656 | ||
| Cyclosporine induces endothelial cell release of complement-activating microparticles | Q37260192 | ||
| Dense deposit disease and C3 glomerulopathy | Q37286653 | ||
| Complement activation: an emerging player in the pathogenesis of cardiovascular disease | Q37288362 | ||
| Rational engineering of a minimized immune inhibitor with unique triple-targeting properties | Q37300691 | ||
| Fibrinogen-specific antibody induces abdominal aortic aneurysm in mice through complement lectin pathway activation | Q37319631 | ||
| Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies | Q37349469 | ||
| Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor | Q37373855 | ||
| Properdin: emerging roles of a pattern-recognition molecule. | Q37641361 | ||
| Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection. | Q37701996 | ||
| Platelet–Leukocyte Interactions in Cardiovascular Disease and Beyond | Q37808902 | ||
| Native properdin binds to Chlamydia pneumoniae and promotes complement activation | Q37851796 | ||
| Platelets and the immune continuum | Q37857647 | ||
| Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents | Q37897674 | ||
| Platelet-leukocyte interactions in thrombosis | Q37954861 | ||
| Platelet-leukocyte deregulated interactions foster sterile inflammation and tissue damage in immune-mediated vessel diseases. | Q37975846 | ||
| The tick-over theory revisited: is C3 a contact-activated protein? | Q38042224 | ||
| Properdin in complement activation and tissue injury | Q38118454 | ||
| Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands. | Q38205436 | ||
| Complement and platelets: Mutual interference in the immune network | Q38426499 | ||
| The membrane attack complex as an inflammatory trigger | Q38468111 | ||
| Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site | Q38596477 | ||
| The many faces of Mac-1 in autoimmune disease | Q38673428 | ||
| Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro | Q38770928 | ||
| Monomeric C-reactive protein inhibits renal cell-directed complement activation mediated by properdin | Q38785657 | ||
| Properdin provides protection from Citrobacter rodentium-induced intestinal inflammation in a C5a/IL-6-dependent manner | Q38905276 | ||
| Neutrophil elastase and proteinase-3 trigger G protein-biased signaling through proteinase-activated receptor-1 (PAR1). | Q39093865 | ||
| Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H. | Q39154806 | ||
| Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. | Q39154817 | ||
| Complement activation by tubular cells is mediated by properdin binding | Q39946407 | ||
| Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation | Q39980543 | ||
| Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation | Q40161972 | ||
| TREM-1 ligand expression on platelets enhances neutrophil activation | Q40220719 | ||
| Complement Factor H-Related 5-Hybrid Proteins Anchor Properdin and Activate Complement at Self-Surfaces | Q40775694 | ||
| Activation of the alternative pathway of human complement by autologous cells expressing transmembrane recombinant properdin | Q40840566 | ||
| Identification of complement regulatory domains in human factor H | Q71700078 | ||
| Intercellular adhesion molecule-2 (CD102) binds to the leukocyte integrin CD11b/CD18 through the A domain | Q71746765 | ||
| Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H | Q71860156 | ||
| Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils | Q73287589 | ||
| Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: correlation with leukocyte recruitment to adherent platelets 1 hour after injury | Q73919572 | ||
| Properdin, the positive regulator of complement, is highly C-mannosylated | Q73947959 | ||
| Inhibition of complement alternative pathway function with anti-properdin monoclonal antibodies | Q74128109 | ||
| Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits | Q74131707 | ||
| Expression and characterisation of the thrombospondin type I repeats of human properdin | Q74403037 | ||
| Identification of the second heparin-binding domain in human complement factor H | Q74412035 | ||
| Expression of properdin in complete and incomplete deficiency: normal in vitro synthesis by monocytes in two cases with properdin deficiency type II due to distinct mutations | Q77117463 | ||
| Role of C3 cleavage in monocyte activation during extracorporeal circulation | Q78077727 | ||
| Selectin blockade reduces neutrophil interaction with platelets at the site of deep arterial injury by angioplasty in pigs | Q78111883 | ||
| Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation | Q78199173 | ||
| Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces | Q79287502 | ||
| Leukocyte effects of C5a-receptor blockade during simulated extracorporeal circulation | Q79447205 | ||
| A novel mechanism of complement inhibition unmasked by a tick salivary protein that binds to properdin | Q80825305 | ||
| The dimeric and trimeric solution structures of the multidomain complement protein properdin by X-ray scattering, analytical ultracentrifugation and constrained modelling | Q80877982 | ||
| The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation | Q81009325 | ||
| Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients | Q81159456 | ||
| Properdin deficiency in murine models of nonseptic shock | Q81206638 | ||
| Complement alternative pathway acts as a positive feedback amplification of neutrophil activation | Q82382595 | ||
| Functional significance of factor H binding to Neisseria meningitidis | Q83918204 | ||
| The role of neutrophils in severe sepsis | Q95807322 | ||
| Complement and its receptors: new insights into human disease | Q28307316 | ||
| Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products | Q28610971 | ||
| Molecular architecture of human properdin, a positive regulator of the alternative pathway of complement | Q28610991 | ||
| Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway | Q28611040 | ||
| Complement: a key system for immune surveillance and homeostasis | Q29615484 | ||
| Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. | Q30310323 | ||
| The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome. | Q30377280 | ||
| Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis | Q30415634 | ||
| CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury | Q30441065 | ||
| Platelet-neutrophil-interactions: linking hemostasis and inflammation | Q30441637 | ||
| Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin. | Q30543168 | ||
| Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. | Q33335833 | ||
| Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site | Q33341100 | ||
| Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome | Q33344817 | ||
| Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome | Q33345226 | ||
| Factor H binds to washed human platelets. | Q33364421 | ||
| Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains | Q33375335 | ||
| Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. | Q33377799 | ||
| Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation | Q33378612 | ||
| Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome | Q33384039 | ||
| Platelet-associated complement factor H in healthy persons and patients with atypical HUS. | Q33385950 | ||
| Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1 | Q33388175 | ||
| Complement activation on platelets: implications for vascular inflammation and thrombosis | Q33390662 | ||
| Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome | Q33394691 | ||
| Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions | Q33405609 | ||
| Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome | Q33430961 | ||
| Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. | Q33558301 | ||
| A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples. | Q33568131 | ||
| Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage | Q33680856 | ||
| Contribution of chondroitin sulfate A to the binding of complement proteins to activated platelets | Q33707764 | ||
| Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease | Q33764140 | ||
| Properdin deficiency: molecular basis and disease association | Q33852651 | ||
| Complement control protein factor H: the good, the bad, and the inadequate. | Q34067107 | ||
| Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance | Q34068498 | ||
| Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy | Q40873835 | ||
| The C-terminus of factor H: monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteins | Q41044029 | ||
| Properdin Regulation of Complement Activation Affects Colitis in Interleukin 10 Gene-Deficient Mice. | Q41261204 | ||
| Characterization of complement factor H binding to Yersinia enterocolitica serotype O:3. | Q41442818 | ||
| Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells | Q41529943 | ||
| The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase | Q41761011 | ||
| Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification | Q41822812 | ||
| Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37. | Q41825787 | ||
| Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes | Q41894352 | ||
| Resolution and analysis of 'native' and 'activated' properdin | Q42065766 | ||
| Complete primary structure of human properdin: a positive regulator of the alternative pathway of the serum complement system | Q42137607 | ||
| Complement proteins C5b-9 stimulate procoagulant activity through platelet prothrombinase. | Q42144043 | ||
| Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement | Q42242306 | ||
| The role of properdin in zymosan- and Escherichia coli-induced complement activation | Q42285785 | ||
| Effect of complement proteins C5b-9 on blood platelets. Evidence for reversible depolarization of membrane potential | Q42435868 | ||
| An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy. | Q42625961 | ||
| Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity. | Q43222930 | ||
| Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H. | Q43292217 | ||
| Myeloperoxidase influences the complement regulatory function of modified C-reactive protein | Q43702621 | ||
| Genetic and environmental factors influencing the human factor H plasma levels | Q43958315 | ||
| Synthesis of platelet-activating factor by polymorphonuclear neutrophils stimulated with interleukin-8. | Q44135612 | ||
| Circulating platelet-leukocyte aggregates in patients with inflammatory bowel disease | Q44315190 | ||
| Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly | Q44441855 | ||
| Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation | Q44781829 | ||
| P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils | Q44951891 | ||
| Platelet activation in cystic fibrosis | Q45261261 | ||
| The role of properdin in murine zymosan-induced arthritis | Q45411990 | ||
| The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation | Q46367570 | ||
| Neutron and X-ray scattering studies on the human complement protein properdin provide an analysis of the thrombospondin repeat | Q46764067 | ||
| The role of properdin in the assembly of the alternative pathway C3 convertases of complement | Q46814862 | ||
| High molecular weight kininogen regulates platelet-leukocyte interactions by bridging Mac-1 and glycoprotein Ib. | Q47443298 | ||
| Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange. | Q48059014 | ||
| An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae | Q34105747 | ||
| Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury | Q34162118 | ||
| Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement | Q34172424 | ||
| A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2 | Q34185817 | ||
| Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate. | Q34344501 | ||
| Complement System Part I - Molecular Mechanisms of Activation and Regulation | Q34481071 | ||
| Metabolism of properdin in normal subjects and patients with renal disease | Q34482222 | ||
| The role of the anaphylatoxins in health and disease | Q34983578 | ||
| Molecular intercommunication between the complement and coagulation systems | Q35067949 | ||
| Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury | Q35097512 | ||
| Protective role for properdin in progression of experimental murine atherosclerosis. | Q35131403 | ||
| Anti-mouse properdin TSR 5/6 monoclonal antibodies block complement alternative pathway-dependent pathogenesis | Q35149952 | ||
| Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans | Q35187024 | ||
| Binding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-factor H binding protein bactericidal activity | Q35187629 | ||
| Leukocytes and coronary heart disease | Q35622165 | ||
| The critical role of complement alternative pathway regulator factor H in allergen-induced airway hyperresponsiveness and inflammation | Q35659039 | ||
| Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation | Q35763398 | ||
| Antibody directs properdin-dependent activation of the complement alternative pathway in a mouse model of abdominal aortic aneurysm | Q35787311 | ||
| Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein | Q35850975 | ||
| Properdin Contributes to Allergic Airway Inflammation through Local C3a Generation | Q35864604 | ||
| Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes. | Q35990700 | ||
| Role of C5a in inflammatory responses | Q36072464 | ||
| The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps | Q36229261 | ||
| The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis | Q36267933 | ||
| Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement | Q36272704 | ||
| The human complement system in thrombin-mediated platelet function | Q36340436 | ||
| Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex | Q36342752 | ||
| Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes. | Q36346014 | ||
| Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase | Q36358434 | ||
| Modulation of the alternative complement pathways by beta 1 H globulin | Q36359984 | ||
| Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18) | Q36368770 | ||
| Platelet activation leads to activation and propagation of the complement system | Q36403387 | ||
| Complement and properidin deficiencies in meningococcal disease | Q36411073 | ||
| Contact activation of C3 enables tethering between activated platelets and polymorphonuclear leukocytes via CD11b/CD18. | Q51741449 | ||
| C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface | Q52162401 | ||
| Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties | Q52735864 | ||
| A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. | Q53598537 | ||
| Blood platelets activate the classical pathway of human complement. | Q53600476 | ||
| Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction. | Q53708193 | ||
| Complement inhibitor factor H binding to Lyme disease spirochetes is mediated by inducible expression of multiple plasmid-encoded outer surface protein E paralogs. | Q53958156 | ||
| Myeloperoxidase directs properdin-mediated complement activation. | Q54416095 | ||
| Properdin plays a protective role in polymicrobial septic peritonitis. | Q54426191 | ||
| Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. | Q54601092 | ||
| Atypical hemolytic uremic syndrome | Q56591965 | ||
| Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H | Q57089510 | ||
| Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques | Q57132361 | ||
| Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule | Q58411952 | ||
| Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the beta 2 integrin CD11b/CD18 | Q58411981 | ||
| Generation of C5a in the absence of C3: a new complement activation pathway | Q58523865 | ||
| Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets | Q59065667 | ||
| The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification | Q63728042 | ||
| Characterization of the initial C3 convertase of the alternative pathway of human complement. | Q64902892 | ||
| On the mechanism by which complement proteins C5b-9 increase platelet prothrombinase activity | Q67273787 | ||
| Localization of the heparin-binding site on complement factor H | Q67902469 | ||
| Properdin binds to sulfatide [Gal(3-SO4)beta 1-1 Cer] and has a sequence homology with other proteins that bind sulfated glycoconjugates | Q68708720 | ||
| Induction of prostanoid synthesis in human platelets by the late complement components C5b-9 and channel forming antibiotic nystatin: inhibition of the reacylation of liberated arachidonic acid | Q68934597 | ||
| Analysis of the natural polymeric forms of human properdin and their functions in complement activation | Q69934718 | ||
| Effect of platelet-activating factor (PAF) on human platelets | Q70218005 | ||
| Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18 | Q71249326 | ||
| Increased neutrophil-platelet adhesion in patients with unstable angina | Q71571191 | ||
| Anti-complement activity of the Ixodes scapularis salivary protein Salp20. | Q36422019 | ||
| Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency | Q36509318 | ||
| Local release of properdin in the cellular microenvironment: role in pattern recognition and amplification of the alternative pathway of complement. | Q36540594 | ||
| Abrogated RANKL expression in properdin-deficient mice is associated with better outcome from collagen-antibody-induced arthritis. | Q36633356 | ||
| Characterization of mutant forms of recombinant human properdin lacking single thrombospondin type I repeats. Identification of modules important for function. | Q36672763 | ||
| Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis | Q36714001 | ||
| The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis. | Q36752476 | ||
| Platelet-leukocyte interactions in inflammation and atherothrombosis | Q36752801 | ||
| Properdin-Mediated C5a Production Enhances Stable Binding of Platelets to Granulocytes in Human Whole Blood | Q36955789 | ||
| Platelet mediated complement activation | Q37088046 | ||
| Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets | Q37170034 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| thrombosis | Q261327 | ||
| globulins | Q321710 | ||
| blood proteins | Q425056 | ||
| complement system proteins | Q67999591 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 172-190 | |
| P577 | publication date | 2016-11-01 | |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | Properdin: a tightly regulated critical inflammatory modulator | |
| P478 | volume | 274 |
| Q107603134 | Alternative pathway C3 convertase complex C3bBb |
| Q107603133 | Alternative pathway fluid-phase C3 convertase complex C3(H2O)Bb |
| Q107603137 | Alternative pathway pathogen cell-bound C3 convertase complex C3bBbP |
| Q107603138 | Alternative pathway pathogen cell-bound C5 convertase complex C3bBbC3bP |
| Q107603136 | Alternative pathway solid-phase C5 convertase complex C3bBbC3b |
| Q49789113 | Advances in our Understanding of the Pathogenesis of Hemolytic Uremic Syndromes. |
| Q58795472 | Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases |
| Q88954752 | Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia |
| Q64041044 | C3 glomerulopathy - understanding a rare complement-driven renal disease |
| Q38558926 | Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense |
| Q33642649 | Complement factor P is a ligand for the natural killer cell-activating receptor NKp46. |
| Q40122524 | Complement factor P: promoting the antibacterial activity of natural killer cells. |
| Q47112418 | Extracellular vesicles from KSHV-infected endothelial cells activate the complement system |
| Q40306147 | Functional and structural insight into properdin control of complement alternative pathway amplification. |
| Q95840971 | Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage |
| Q90265983 | Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b |
| Q89731772 | Mathematical Modelling of Alternative Pathway of Complement System |
| Q92468490 | Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review |
| Q48275427 | Preformed mediators of defense-Gatekeepers enter the spotlight |
| Q98465677 | Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation |
| Q37612601 | Properdin binding to complement activating surfaces depends on initial C3b deposition |
| Q89319775 | Properdin: A multifaceted molecule involved in inflammation and diseases |
| Q55710477 | Retinal Basal Laminar Deposits in Complement fH/fP Mouse Model of Dense Deposit Disease. |
| Q91121470 | Role of Complement and Complement-Related Adipokines in Regulation of Energy Metabolism and Fat Storage |
| Q64993828 | Targeting properdin in the treatment of atypical haemolytic uraemic syndrome: better than eculizumab? |
| Q47336749 | The renaissance of complement therapeutics. |
| Q64286426 | The viral protein corona directs viral pathogenesis and amyloid aggregation |
| Q91474110 | Thromboinflammatory changes in plasma proteome of pregnant women with PCOS detected by quantitative label-free proteomics |
| Q90257092 | Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity |
Search more.